Skip to main content

Closed

HALO: Halozyme Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

93thpctl

Volume

0.81×avg

Market Cap

9.79BUSD

P/E Ratio

28.5TTM

Div Yield

-ann

Halozyme Therapeutics, Inc.

HALONASDAQ Global Select·USD·Closed

Halozyme Therapeutics, Inc.

HALONASDAQ·USD·Closed

$82.54

−0.91%

$82.54

−$0.76 (0.91%)

52W Range

93thpctl

Volume

0.81×avg

Mkt Cap

9.79BUSD

P/E

28.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings